Cargando…
Oxaliplatin but Not Irinotecan Impairs Posthepatectomy Liver Regeneration in a Murine Model
Introduction. We examined the murine hepatectomy model of liver regeneration (LR) in the setting of neoadjuvant chemotherapy. Methods. C57BL/6 mice were randomized to receive neoadjuvant intraperitoneal (IP) injections of a control, oxaliplatin (15 mg/kg), or irinotecan (100 mg/Kg or 250 mg/Kg) solu...
Autores principales: | Soriano, Perry A., Liu, Nian, Castillo, Erick, Foster, Brock, Artinyan, Avo, Kim, Joseph, Huang, Wendong, Wagman, Lawrence D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230113/ https://www.ncbi.nlm.nih.gov/pubmed/22164336 http://dx.doi.org/10.4061/2011/490463 |
Ejemplares similares
-
Posthepatectomy liver failure
por: OCAK, İlhan, et al.
Publicado: (2020) -
Current evidence on posthepatectomy liver failure: comprehensive review
por: Sparrelid, Ernesto, et al.
Publicado: (2022) -
Validation of a surgical model for posthepatectomy liver failure in rats
por: Lund, Andrea, et al.
Publicado: (2023) -
Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma
por: Granda, T G, et al.
Publicado: (2002) -
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2003)